Advertisement

Reproductive Sciences

, Volume 19, Issue 1, pp 55–63 | Cite as

Temporal Investigation of Matrix Metalloproteinases and Their Inhibitors in Human Cervicovaginal Fluid in Late Pregnancy and Labor

  • Yujing J. Heng
  • Megan K. W. Di Quinzio
  • Stella Liong
  • Michael Permezel
  • Gregory E. Rice
  • Harry M. GeorgiouEmail author
Original Articles

Abstract

Temporal expression of matrix metalloproteinase (MMP)-1, -2, -3, -7, -8, -9, -12, and -13, and tissue inhibitors of metalloproteinases (TIMPs)-1 and -2 in human cervicovaginal fluid (CVF) in term pregnancy and labor was investigated. Term parous women provided CVF samples that were grouped into labor, 1 to 3, 6 to 8, and 12 to 16 days before labor onset. Both MMPs and TIMPs (n = 60) were quantified using multiplex solution array and enzyme-linked immunosorbent assays, respectively. Further analysis of TIMP-1 (n = 180) was undertaken. All MMPs and TIMPs except MMP-12 and -13 were detected in the CVF. Matrix metalloproteinase 7, TIMP-1, and TIMP-2 were significantly increased in labor. Tissue inhibitors of metalloproteinase 1 was significantly increased up to 7 days before spontaneous labor onset. The data suggest a role of MMP-7 in the remodeling and rupture of fetal membranes and may reflect the homeostatic regulation of extracellular matrix remodeling of MMP-7 by TIMP-1 and TIMP-2.

Keywords

cervicovaginal fluid labor matrix metalloproteinases pregnancy tissue inhibitors of matrix metalloproteinases 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci. 2007;12:649–659.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Nagase H, Woessner Jr, JF. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491–21494.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803(1):55–71.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Sennström MB, Brauner A, Byström B, Malmström A, Ekman G. Matrix metalloproteinase-8 correlates with the cervical ripening process in humans. Acta Obstet Gynecol Scand. 2003;82(10): 904–911.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Stygar D, Wang H, Vladic YS, et al. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod. 2002;67(3):889–894.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Watari M, Watari H, DiSanto ME, et al. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol. 1999;154(6): 1755–1762.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Yoshida M, Sagawa N, Itoh H, et al. Nitric oxide increases matrix metalloproteinase-1 production in human uterine cervical fibroblast cells. Mol Hum Reprod. 2001;7(10):979–985.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Ledingham MA, Denison FC, Riley SC, Norman JE. Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. Hum Reprod. 1999;14(8):2089–2096.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab. 2002;87(3):1353–1361.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Nishihara S, Someya A, Yonemoto H, et al. Evaluation of the expression and enzyme activity of matrix metalloproteinase-7 in fetal membranes during premature rupture of membranes at term in humans. Reprod Sci. 2008;15(2):156–165.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Fortunato SJ, Menon R. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes. J Assist Reprod Genet. 2002;19(10):483–486.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta. 2006; 27(11–12):1037–1051.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Roh CR, Oh WJ, Yoon BK, Lee JH. Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod. 2000;6(1):96–102.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol. 2000;183(1):94–99.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes. Am J Reprod Immunol. 1998;40(6):395–400.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Becher N, Hein M, Danielsen CC, Uldbjerg N. Matrix metalloproteinases and their inhibitor in the cervical mucus plug at term of pregnancy. Am J Obstet Gynecol. 2004;191(4):1232–1239.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Becher N, Hein M, Danielsen CC, Uldbjerg N. Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor. Reprod Biol Endocrinol. 2010;8:113.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Becher N, Hein M, Uldbjerg N, Danielsen CC. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP. Reprod Biol Endocrinol. 2008;6:45.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Choi SJ, Jung KL, Oh SY, Kim JH, Roh CR. Cervicovaginal matrix metalloproteinase-9 and cervical ripening in human term parturition. Eur J Obstet Gynecol Reprod Biol. 2009;142(1): 43–47.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Rahkonen L, Rutanen EM, Nuutila M, et al. Matrix metalloproteinase-8 in cervical fluid in early and mid pregnancy: relation to spontaneous preterm delivery. Prenat Diagn. 2010; 30(11):1079–1085.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Di Quinzio MK, Oliva K, Holdsworth SJ, et al. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust N Z J Obstet Gynaecol. 2007;47(1):9–15.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Heng YJ, Di Quinzio MK, Permezel M, Rice GE, Georgiou HM. Interleukin-1 receptor antagonist in human cervicovaginal fluid in term pregnancy and labor. Am J Obstet Gynecol. 2008;199(6):656.1–7.CrossRefGoogle Scholar
  23. 23.
    Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297–301.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Kolkenbrock H, Orgel D, Hecker-Kia A, Noack W, Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem. 1991;198(3):775–781.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Crabbe T, Willenbrock F, Eaton D, et al. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry. 1992;31(36):8500–8507.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Miyazaki K, Funahashi K, Numata Y, et al. Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein. J Biol Chem. 1993;268(19):14387–14393.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Maymon E, Romero R, Pacora P, et al. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol. 2000;182(6): 1545–1553.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Woessner JF. Matrix metalloproteinase inhibition. From The jurassic to the third millennium. Ann N Y Acad Sci. 1999;878:388–403.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Murphy G, Cockett MI, Ward RV, Docherty AJ. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991;277(pt 1):277–279.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Heng YJ, Di Quinzio MK, Permezel M, et al. Temporal proteomic analysis of human cervicovaginal fluid with impending term labor. J Proteome Res. 2010;9(3):1344–1350.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Goldman S, Weiss A, Eyali V, Shalev E. Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod. 2003;9(6):367–373.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    McLaren J, Taylor DJ, Bell SC. Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol. 2000;182(2):409–416.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Agrez M, Gu X, Giles W. Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery. Am J Obstet Gynecol. 1999;181(2):387–388.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Romero R, Chaiworapongsa T, Espinoza J, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 2002;187(5):1125–1130.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med. 2001;29(4):308–316.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Ota A, Yonemoto H, Someya A, et al. Changes in matrix metalloproteinase 2 activities in amnionchorions during premature rupture of membranes. J Soc Gynecol Investig. 2006;13(8):592–597.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Riley SC, Leask R, Denison FC, et al. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol. 1999;162(3): 351–359.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Pentland AP, Shapiro SD, Welgus HG. Agonist-induced expression of tissue inhibitor of metalloproteinases and metalloproteinases by human macrophages is regulated by endogenous prostaglandin E2 synthesis. J Invest Dermatol. 1995;104(1): 52–57.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Leppert PC. Cervical softening, effacement and dilatation: a complex biochemical cascade. J Matern Fetal Med. 1992;1:213–223.CrossRefGoogle Scholar
  40. 40.
    Winkler M, Oberpichler A, Tschesche H, et al. Collagenolysis in the lower uterine segment during parturition at term: correlations with stage of cervical dilatation and duration of labor. Am J Obstet Gynecol. 1999;181(1):153–158.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Athayde N, Romero R, Gomez R, et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med. 1999;8(5):213–219.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Leitich H, Egarter C, Kaider A, et al. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 1999;180(5):1169–1176.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Honest H, Bachamann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ. 2002; 325(7359):301.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol. 2009;114(3):631–640.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Imai M, Tani A, Saito M, et al. Significance of fetal fibronectin and cytokine measurement in the cervicovaginal secretions of women at term in predicting term labor and post-term pregnancy. Eur J Obstet Gynaecol Reprod Biol. 2001;97(1):53–58.CrossRefGoogle Scholar
  46. 46.
    Timmons BC, Mahendroo M. Processes regulating cervical ripening differ from cervical dilation and postpartum repair: insights from gene expression studies. Reprod Sci. 2007; 14(8 suppl):53–62.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Society for Reproductive Investigation 2012

Authors and Affiliations

  • Yujing J. Heng
    • 1
    • 2
  • Megan K. W. Di Quinzio
    • 1
    • 2
  • Stella Liong
    • 1
    • 2
  • Michael Permezel
    • 1
    • 2
  • Gregory E. Rice
    • 1
    • 3
  • Harry M. Georgiou
    • 1
    • 2
    • 4
    Email author
  1. 1.Department of Obstetrics and GynaecologyThe University of MelbourneParkvilleAustralia
  2. 2.Mercy Perinatal Research CentreMercy Hospital for WomenHeidelbergAustralia
  3. 3.University of Queensland Centre for Clinical ResearchHerstonAustralia
  4. 4.University Department, Mercy Hospital for WomenHeidelbergAustralia

Personalised recommendations